the endocrine system - mycme...endocrine system maria alonso, cde, pa-c umdnj pance/panre review...

69
UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013 Endocrine System Endocrine System Maria Alonso, CDE, PA Maria Alonso, CDE, PA - - C C UMDNJ PANCE/PANRE Review Course UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013) (becoming Rutgers July 1, 2013) The Endocrine System The Endocrine System Disease of the Pituitary Gland Disease of the Pituitary Gland Diseases of the Thyroid Diseases of the Thyroid Disease of the Adrenal Glands Disease of the Adrenal Glands Diabetes Mellitus Diabetes Mellitus Lipid Disorders Lipid Disorders UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013) http://commons.wikimedia.org/wiki/File:Illu_endocrine_system.jpg UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

Upload: others

Post on 25-Jan-2021

2 views

Category:

Documents


0 download

TRANSCRIPT

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Endocrine SystemEndocrine System

    Maria Alonso, CDE, PAMaria Alonso, CDE, PA--CC

    UMDNJ PANCE/PANRE Review Course UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)(becoming Rutgers July 1, 2013)

    The Endocrine SystemThe Endocrine System

    Disease of the Pituitary GlandDisease of the Pituitary Gland

    Diseases of the ThyroidDiseases of the Thyroid

    Disease of the Adrenal GlandsDisease of the Adrenal Glands

    Diabetes MellitusDiabetes Mellitus

    Lipid DisordersLipid DisordersUMDNJ PANCE/PANRE Review Course

    (becoming Rutgers July 1, 2013) http://commons.wikimedia.org/wiki/File:Illu_endocrine_system.jpgUMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Pituitary Gland Pituitary Gland

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Pituitary AnatomyPituitary Anatomy

    Public domain available at:http://commons.wikimedia.org/wiki/File:Grays_pituitary.png

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    PITUITARY ANATOMYPITUITARY ANATOMY

    •Small pea-sized gland at the base of brain•Located in the “Sella Turcica”•Functions as "The Master Gland" •Attached below hypothalamus by stalk•Large anterior lobe (adenohypophysis)•Smaller posterior lobe (neurohypophysis)•The optic chiasm lies directly above•Supplied by internal carotid artery

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Quick ReviewQuick Review

    Hypothalamus

    GnRH GHRH SS TRH DA CRH

    + +++ _ _

    Anterior Pituitary

    ACTHProlactinTSHGH/TSH GHFSH/LH

    Gonadotropin releasing hormone (GnRH). Growth hormone releasing hormone (GHRH)

    Somatostatin (SS), Thyrotropin releasing hormone (TRH), Dopamine (DA)

    Corticotropin releasing hormone (CRH)UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Posterior PituitaryOxytocin ADH

    Hypothalamus

    Quick Review

    + +

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Quick Review: Hypothalamic Quick Review: Hypothalamic Pituitary AxisPituitary Axis

    NeurosecretoryNeurosecretory cellscells send messages from send messages from brain to brain to hypothalamushypothalamusHypothalamus sends chemical hormones Hypothalamus sends chemical hormones to the to the pituitary glandpituitary glandPituitary gland secretes hormones to the Pituitary gland secretes hormones to the thyroid gland, adrenal glands, and gonadsthyroid gland, adrenal glands, and gonadsNegative feedback mechanism finishes the Negative feedback mechanism finishes the looploop

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Pituitary DisordersPituitary Disorders

    HypopituitarismHypopituitarism –– Congenital causesCongenital causes

    HypopituitarismHypopituitarism-- Acquired causesAcquired causes

    Pituitary tumors (adenomas)Pituitary tumors (adenomas)

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    HypopituitarismHypopituitarism-- Congenital CausesCongenital Causes

    Hypothalamic gene defectsHypothalamic gene defectsPituitary gene defectsPituitary gene defectsHormone receptor gene defectsHormone receptor gene defectsAnencephaly, neural tube defectAnencephaly, neural tube defectPituitary Pituitary aplasiaaplasia, usually fatal at birth, usually fatal at birthKallmannKallmann syndrome: xsyndrome: x--recessive recessive GnRHGnRHdefect with defect with hypogonadismhypogonadism, delayed , delayed puberty, osteoporosis, puberty, osteoporosis, anosmiaanosmia

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    HYPOPITUITARISM HYPOPITUITARISM ACQUIRED CAUSESACQUIRED CAUSES

    TumorsTumors are the most common cause in adultsare the most common cause in adultsIrradiationIrradiation for other cranial tumorsfor other cranial tumorsVascular:Vascular: bleed, infarct, Sheehanbleed, infarct, Sheehan’’ssInflammatory:Inflammatory: sarcoidosissarcoidosis, TB, TBMetabolic:Metabolic: Fe deposits/Fe deposits/hemochromatosishemochromatosis, , amyloidosisamyloidosis, illness, malnutrition, illness, malnutrition

    **Empty **Empty SellaSella Syndrome:Syndrome:unable to see gland on imaging due to any of unable to see gland on imaging due to any of above. May have shrunk or flattened above. May have shrunk or flattened

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Pituitary TumorsPituitary Tumors

    MicroadenomasMicroadenomas (10mm)Rarely malignantRarely malignantLocally invasiveLocally invasive

    destroy hormone producing cellsdestroy hormone producing cellscompresses gland or hypothalamuscompresses gland or hypothalamus

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Types of AdenomasTypes of Adenomas

    ProlactinomaProlactinoma prolactin/hypogonadismprolactin/hypogonadism and and galactorrheagalactorrhea(25(25--40%) (40%) (LactotrophLactotroph))

    Null cell Null cell no active hormone (10no active hormone (10--25%)25%)SomatotrophSomatotroph GH/GH/acromegalyacromegaly and gigantism (10and gigantism (10--15%)15%)CorticotrophCorticotroph ACTH/ CushingACTH/ Cushing’’s (10s (10--15%)15%)GonadotrophGonadotroph FSH/LH (15FSH/LH (15--20%)20%)ThyrotrophThyrotroph TSH/ hyperthyroidism (1%)TSH/ hyperthyroidism (1%)

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Clinical ManifestationsClinical Manifestations

    Mass effectMass effectheadachesheadachesbitemporalbitemporal hemianopsiahemianopsiaDiplopiaDiplopia

    Symptoms based on hormone involvedSymptoms based on hormone involved

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    TreatmentsTreatmentsMedical therapyMedical therapy--

    decreases hormone and tumordecreases hormone and tumordopamine agonistdopamine agonist-- BromocriptineBromocriptinereplace hormones (thyroid/adrenal) replace hormones (thyroid/adrenal)

    Surgical excisionSurgical excisionTranssphenoidalTranssphenoidalGamma Knife/ Stereotactic NonGamma Knife/ Stereotactic Non--invasive invasive Radio SurgeryRadio Surgery

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    ProlactinomaProlactinoma 2525--40%40%Occurs M/C 20Occurs M/C 20--50 50 yoyoHyperprolactinemiaHyperprolactinemiaHypogonadismHypogonadism

    negative effect on negative effect on GnRHGnRHreduction in LH and FSHreduction in LH and FSH

    Females Females -- galactorrheagalactorrhea, , oligomenorrheaoligomenorrhea, , amenorrheaamenorrheaMalesMales-- headache, visual disturbance, headache, visual disturbance, impotenceimpotence

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    ProlactinProlactinDopamine inhibits Dopamine inhibits prolactinprolactin secretionsecretion

    Estrogen, TRH, and GHRH positively effect Estrogen, TRH, and GHRH positively effect prolactinprolactin secretionsecretion

    Excess can be caused by lactation, Excess can be caused by lactation, tumors, drugs, hypothyroidism, tumors, drugs, hypothyroidism, hypothalamic dysfunctionhypothalamic dysfunction

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    ProlactinomaProlactinomaWork up:Work up:

    BHCG, BHCG, prolactinprolactin level, TSHlevel, TSHCT/MRI of the BrainCT/MRI of the Brain

    DDxDDx: : excessive exerciseexcessive exerciseHxHx chest wall surgerychest wall surgerychest trauma chest trauma renal failurerenal failurecirrhosiscirrhosis

    TX : TX : dopamine agonistdopamine agonist-- BromocriptineBromocriptineSurgical excisionSurgical excision

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Excessive Growth Hormone Excessive Growth Hormone SecretionSecretion

    AcromegalyAcromegaly –– adultsadultsAfterAfter epiphysealepiphyseal closureclosure

    Gigantism Gigantism –– childrenchildrenBeforeBefore epiphysealepiphyseal closure (excessive height)closure (excessive height)

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Excessive Growth HormoneExcessive Growth Hormone

    98% cases adenomas is the cause98% cases adenomas is the cause

    Usually mixed cell tumorsUsually mixed cell tumors

    Increase riskIncrease risk-- DM, HTN, CADDM, HTN, CAD

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Physical ManifestationsPhysical Manifestations

    Enlargement of extremitiesEnlargement of extremitieshands doughy / large handshands doughy / large hands

    Coarse facial featuresCoarse facial featuresprominent mandible, brow, nose, prominent mandible, brow, nose, lips, tonguelips, tongue

    Coarse, oily, thick skinCoarse, oily, thick skinOrganomegalyOrganomegaly

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Prominent jaw/ BrowProminent jaw/ Brow

    Public domain available at:http://commons.wikimedia.org/wiki/File:Acromegaly_facial_features.JPEG

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Hands doughy / Large handsHands doughy / Large hands

    Public domain available at: http://commons.wikimedia.org/wiki/File:Acromegaly_hands.JPEG UMDNJ PANCE/PANRE Review Course

    (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Related ConditionsRelated Conditions

    MusclosketalMusclosketalCardiacCardiacMetabolicMetabolicSleep apneaSleep apnea

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Related ConditionsRelated ConditionsMusculoskeletalMusculoskeletal

    Hypertrophy of joint cartilage and Hypertrophy of joint cartilage and synovial tissuesynovial tissue

    carpal tunnel syndromecarpal tunnel syndromearthritisarthritisarthralgiaarthralgia

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Related ConditionsRelated Conditions

    CardiacCardiacLeft ventricular hypertrophy Left ventricular hypertrophy Diastolic dysfunctionDiastolic dysfunctionDysrhythmiasDysrhythmiasHypertensionHypertension

    MetabolicMetabolicInsulin resistance, glucose intolerance, DMInsulin resistance, glucose intolerance, DM

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Labs/ Diagnostic TestsLabs/ Diagnostic TestsLabsLabs

    GH and IGFGH and IGF--1: 5x normal in 1: 5x normal in acromegalyacromegalyProlactinProlactin, glucose, glucoseLiver enzymes, Blood urea Liver enzymes, Blood urea nitrogen(BUNnitrogen(BUN))CalciumCalciumSerum FT4 and TSHSerum FT4 and TSH

    Glucose Suppression test = DiagnoseGlucose Suppression test = DiagnoseGlucose should suppress GH, in Glucose should suppress GH, in acromegalyacromegaly it it does notdoes not

    Imaging: MRIImaging: MRIUMDNJ PANCE/PANRE Review Course

    (becoming Rutgers July 1, 2013)

    TreatmentTreatmentSurgical Surgical (50% success (50% success w/macroadenomasw/macroadenomas))

    RadiotherapyRadiotherapy

    Medical TherapyMedical TherapyDopamine AgonistDopamine Agonist-- ((brocriptinebrocriptine))

    GH Receptor GH Receptor AntagnoistAntagnoist-- ((PegvisomantPegvisomant))

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    DwarfismDwarfismLess than 4Less than 4’’1010”” is heightis height

    DisproportionateDisproportionate-- skeletal skeletal dysplasiadysplasia

    AchondroplasiaAchondroplasiaShortShort--trunk dwarftrunk dwarf

    ProportionateProportionate-- medical or medical or genetic conditionsgenetic conditions

    Growth hormoneGrowth hormonedeficiencydeficiency

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Public domain available at:http://commons.wikimedia.org/wiki/File:Paul_Steven_Miller_EEOC.jpg

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    AchondroplasiaAchondroplasiaMutations in the FGFR3 gene Autosomal dominantShort stature < 4Short stature < 4’’1010””OverweightOverweightShort limbsShort limbsProminent browProminent browMidfacialMidfacial hypoplasiahypoplasia

    Public domain available at:http://commons.wikimedia.org/wiki/File:Jason_Acu%C3%B1a_-_Wee-Man_-_Waterfront_Marriott,_Portland,_Oregon_-_August_15,_2009_-_Full_Body.jpg

    UMDNJ PANCE/PANRE Review Course UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)(becoming Rutgers July 1, 2013)

    Growth Hormone DeficiencyGrowth Hormone Deficiency

    Insufficient GHRH from hypothalamusInsufficient GHRH from hypothalamusInsufficient production of GH by pituitary Insufficient production of GH by pituitary Genetic MutationGenetic Mutation-- GHRHR, GH1GHRHR, GH1AcquiredAcquired-- tumors/irradiationtumors/irradiationIdiopathicIdiopathic-- M/CM/CGenetic disordersGenetic disorders-- Turner, Noonan, PWSTurner, Noonan, PWSSGASGA

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Stimulation TestStimulation Test

    Gold Standard Insulin Tolerance Test (ITT), then Gold Standard Insulin Tolerance Test (ITT), then another agent another agent clonidineclonidine, L, L--DopaDopa, glucagon, , glucagon, argininearginine or or GhRHGhRH should cause an increase in should cause an increase in GH levelsGH levelsStimulation test measures the level of Stimulation test measures the level of growth growth hormonehormone (GH) in the blood after stimulation (GH) in the blood after stimulation The test measures the ability of the pituitary The test measures the ability of the pituitary gland to release GH under stimulationgland to release GH under stimulation

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    GROWTH HORMONE GROWTH HORMONE REPLACEMENTREPLACEMENT

    SomatotropinSomatotropin given as daily SQ injection given as daily SQ injection until bone fusion (Bone Age)until bone fusion (Bone Age)May not need further treatment as adults, May not need further treatment as adults, consider repeating stimulation testconsider repeating stimulation testSide effects include headaches, carpal Side effects include headaches, carpal tunnel, SKFE, tunnel, SKFE, arthralgiasarthralgias, and edema, and edemaMonitor for scoliosisMonitor for scoliosis

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Diabetes Diabetes InsipidusInsipidus

    Vasopressin (ADH): AntiVasopressin (ADH): Anti--Diuretic HormoneDiuretic Hormone

    Synthesized in hypothalamus: stored and Synthesized in hypothalamus: stored and released from released from posterior pituitaryposterior pituitaryTwo Main forms: Two Main forms:

    Central (neurogenic): Central (neurogenic): deficiency of ADH, low deficiency of ADH, low secretion, secretion, most commonly seenmost commonly seenNephrogenicNephrogenic: resistance to ADH: resistance to ADH

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    CentralCentral Diabetes Diabetes InsipidusInsipidus = = LOW LOW ADHADH

    Disruption of the normal production, Disruption of the normal production, storage and release of ADHstorage and release of ADH

    Primary:Primary: No organic lesion, autoimmuneNo organic lesion, autoimmuneSecondary:Secondary: damage to hypothalamus or damage to hypothalamus or pituitary stalkpituitary stalk

    Trauma, tumor or illness Trauma, tumor or illness

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    NephrogenicNephrogenic DI = DI = HighHigh ADHADH

    Caused by a Caused by a defectdefect in the kidney tubules in the kidney tubules interferes with water interferes with water reabsorptionreabsorption, , therefore do not respond to ADHtherefore do not respond to ADHCauses: genetic disorder (seen shortly Causes: genetic disorder (seen shortly after birth), CKD, or drugs (lithium)after birth), CKD, or drugs (lithium)

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Other Rare CausesOther Rare CausesCongenital Congenital NephrogenicNephrogenic DI: defective DI: defective expression of renal vasopressin receptorsexpression of renal vasopressin receptors

    Familial XFamilial X--linked traitlinked trait

    DI of Pregnancy: Last trimesterDI of Pregnancy: Last trimesterOligohydramniosOligohydramniosPrePre--eclampsiaeclampsiaHepatic dysfunctionHepatic dysfunction

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Clinical FeaturesClinical Features

    • Polydipsia

    • Polyuria (5-15L daily)

    • Colorless urine (dilute)

    • Dehydration and electrolyte

    imbalance

    Public domain available at:http://commons.wikimedia.org/wiki/File:Glass-of-water.jpg

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    DiagnosisDiagnosis

    Fluid deprivation testFluid deprivation testexcessive intake of fluid (primary polydipsia)defect in ADH productiondefect in the kidneys' response to ADH

    DesmopressinDesmopressin stimulation teststimulation testU/AU/AConsider MRIConsider MRIDiff Diff DxDx: psychogenic : psychogenic polydipsiapolydipsia

    UMDNJ PANCE/PANRE Review Course UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)(becoming Rutgers July 1, 2013)

    Treatment of DITreatment of DI

    Central DI: Central DI: DesmopressinDesmopressin (DDAVP), (DDAVP), CarbamazipineCarbamazipine

    NephrogenicNephrogenic: : ThiazideThiazide diuretics, diuretics, indomethacinindomethacin, , amilorideamiloride (combo)(combo)

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    HYPOTHALAMICHYPOTHALAMIC--PITUITARY PITUITARY --THYROID THYROID AXISAXIS

    Public domain available at:http://commons.wikimedia.org/wiki/File:Thyroid_hormone_feedback.png

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Thyroid GlandThyroid Gland

    HypothyroidismHypothyroidism

    HyperthyroidismHyperthyroidism

    Public domain available at:http://upload.wikimedia.org/wikipedia/commons/3/32/Thyroid_gland-ga.svgUMDNJ PANCE/PANRE Review Course

    (becoming Rutgers July 1, 2013)

    THYROID ANATOMYTHYROID ANATOMY

    Largest endocrine gland in bodyLargest endocrine gland in bodyTwo lobes connected by Two lobes connected by ““isthmusisthmus””Protected by thyroid cartilageProtected by thyroid cartilage

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Public domain available at:http://upload.wikimedia.org/wikipedia/commons/3/32/Thyroid_gland-ga.svg

    FUNCTIONFUNCTION

    T4 is the main hormone secretedT4 is the main hormone secretedOnly 20% of T3 is secreted from thyroidOnly 20% of T3 is secreted from thyroidIodine + tyrosine makes the T3 and T4Iodine + tyrosine makes the T3 and T4T3 is 3T3 is 3--4 times as active as T44 times as active as T4T3 and T4 exist as free and protein boundT3 and T4 exist as free and protein bound

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    THYROID IMAGINGTHYROID IMAGING

    Ultrasound (U/S) is useful to identify nodulesUltrasound (U/S) is useful to identify nodulesU/S guided Fine Needle Aspiration for U/S guided Fine Needle Aspiration for DxDx

    Nuclear scans with radioactive iodineNuclear scans with radioactive iodine--123 or 123 or technetiumtechnetium--99m99mRadioactive iodine uptake test (RAIU) Radioactive iodine uptake test (RAIU)

    evaluates function and helps determine amt. RAI for evaluates function and helps determine amt. RAI for txtx

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Diseases of the Thyroid GlandDiseases of the Thyroid Gland

    HyperthyroidismHyperthyroidismGravesGraves’’ DiseaseDiseaseThyroid stormThyroid storm

    HypothryoidismHypothryoidismHashimotoHashimoto’’s s thyroiditisthyroiditis

    ThyroiditisThyroiditisNeoplasticNeoplastic DiseaseDisease

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    HyperthyroidismHyperthyroidism

    ThyrotoxicosisThyrotoxicosis is the clinical syndromeis the clinical syndromeMore common in women, 2% of societyMore common in women, 2% of societyMost common cause is Most common cause is GravesGraves’’ DiseaseDiseaseOlder patients do not show classic signsOlder patients do not show classic signs

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Hyperthyroidism:Hyperthyroidism:

    Other causes:Other causes:Toxic nodulesToxic nodulesThyroiditisThyroiditisIodine inducedIodine inducedExogenous hormoneExogenous hormone

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Hyperthyroidism in PregnancyHyperthyroidism in Pregnancy

    GravesGraves’’-- most frequent causemost frequent causeBHCGBHCG--a stimulator of thyroid a stimulator of thyroid glandglandDecrease TSH & elevated FT4Decrease TSH & elevated FT4Neonatal mortality 6%Neonatal mortality 6%

    Public domain available at:http://commons.wikimedia.org/wiki/File:Pregnant_woman.jpg

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    GravesGraves’’ DiseaseDisease

    Women > Men (8:1)Women > Men (8:1)onset 20onset 20--40 yrs.40 yrs.Autoimmune disorder Autoimmune disorder

    Thyroid stimulating immunoglobulin antibodyThyroid stimulating immunoglobulin antibody

    Association with other autoimmune Association with other autoimmune disordersdisorders

    SLE, pernicious anemia, RA, DM type 1, MGSLE, pernicious anemia, RA, DM type 1, MGUMDNJ PANCE/PANRE Review Course

    (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    GravesGraves’’ DiseaseDisease

    Affects TSH receptorsAffects TSH receptorsTSH secretionTSH secretionStimulate glandular growthStimulate glandular growthDiffuse, symmetric enlargement/goiterDiffuse, symmetric enlargement/goiterNontenderNontenderThyroid cancer can coincide w/ GravesThyroid cancer can coincide w/ Graves’’!!

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Signs Specific to GravesSigns Specific to Graves’’

    OphthalmopathyOphthalmopathy: : ExopthalmosExopthalmos

    PretibialPretibial myxedemamyxedema

    Thyroid bruitThyroid bruit

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    EXOPHTHALMOSEXOPHTHALMOS

    MucopolysaccharidesMucopolysaccharides/lymphocytes/lymphocytesCauses protrusion of globeCauses protrusion of globeLook of astonishment Look of astonishment ““Stellwag'sStellwag's signsign””-- infrequent blinkinginfrequent blinking

    Upper lid lag on downward gazeUpper lid lag on downward gazeEach eye can be affected differentlyEach eye can be affected differentlyMay see weak upward gaze, May see weak upward gaze, diplopiadiplopiaExcess tearing, photophobia, gritty feelExcess tearing, photophobia, gritty feel

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Public domain available at:http://commons.wikimedia.org/wiki/File:Proptosis_and_lid_retraction_from_Graves%27_Disease.jpg

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Public domain available at:http://commons.wikimedia.org/wiki/File:Myxedema.jpg

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    ThyrotoxicosisThyrotoxicosis Clinical FeaturesClinical FeaturesNervousness, insomnia, irritabilityNervousness, insomnia, irritabilityHand tremor, hyperactivity, tremulousnessHand tremor, hyperactivity, tremulousnessExcessive sweating, heat intoleranceExcessive sweating, heat intoleranceWt. Loss (despite Wt. Loss (despite appetite)appetite)Diarrhea, freq. defecationDiarrhea, freq. defecationPalpitations (Palpitations (tachyarrhythmiastachyarrhythmias))Muscle weaknessMuscle weaknessMenstrual irregularitiesMenstrual irregularities

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Diagnosis of GravesDiagnosis of Graves’’

    T3 and free T4 levels elevatedT3 and free T4 levels elevatedTSH level extremely low or undetectableTSH level extremely low or undetectableAnti-thyroglobulin antibodies (TGA)Anti-thyroid peroxidase antibodies (TPO)24 hr RAIU given orally is increased24 hr RAIU given orally is increased(T4 can be normal = T3 (T4 can be normal = T3 toxicosistoxicosis))

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    DonDon’’t forget false positives!t forget false positives!DrugsDrugsAuto immunityAuto immunityAcute illnessAcute illnessHigh estrogen statesHigh estrogen statesPsychiatric illnessPsychiatric illnessAIDSAIDSAcute use steroidsAcute use steroids

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Treatment TypesTreatment Types

    AntithyroidAntithyroid drugs drugs AblationAblationBeta blockers Beta blockers –– Used to treat symptomsUsed to treat symptoms

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    AntithyroidAntithyroid Drugs Drugs block conversion of T4 to T3block conversion of T4 to T3

    PropylthiouracilPropylthiouracil (PTU)(PTU)taken three x dailytaken three x dailyused in severe cases, pregnancy and breast feedingused in severe cases, pregnancy and breast feedingMethimazoleMethimazole ((TapazoleTapazole) ) taken daily, slower to decrease T3taken daily, slower to decrease T3Levels checked 4 weeks after TX startedLevels checked 4 weeks after TX startedSide effects:Side effects:AgranulocytosisAgranulocytosis, thrombocytopenia, anemia, hepatitis, dermatitis, , thrombocytopenia, anemia, hepatitis, dermatitis, vasculitisvasculitis, , pneumonitispneumonitis, hypoglycemia, urticaria,, hypoglycemia, urticaria,

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Radioiodine 131 (RAI)Radioiodine 131 (RAI)Used in older patientsUsed in older patientsPrior PTU/MMI Prior PTU/MMI reaction or failure, or poor compliance.reaction or failure, or poor compliance.Not to be used in pregnancy/nursingNot to be used in pregnancy/nursingStop Stop antithyroidantithyroid meds 3meds 3--5 days prior5 days priorRAIU used to determine dosingRAIU used to determine dosingImprovement seen after 4Improvement seen after 4--6 weeks6 weeksAlmost 80% are cured with one doseAlmost 80% are cured with one doseAt least 50% will become hypothyroid in a yearAt least 50% will become hypothyroid in a year

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    SurgicalSurgical-- ThyroidectomyThyroidectomyIndicated for large obstructing glands, Indicated for large obstructing glands, malignant nodules, or pregnancymalignant nodules, or pregnancyMust be Must be euthyroideuthyroid before surgerybefore surgeryPotassium iodide may be given priorPotassium iodide may be given priorComplications:Complications:

    recurrent laryngeal nerve damagerecurrent laryngeal nerve damagebleedingbleedinghypoparathyroidismhypoparathyroidism

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Keys to Choosing Keys to Choosing TxTx

    NonNon--pregnant Gravespregnant Graves’’ patientspatientsMethimazoleMethimazole + Beta blocker+ Beta blockerRAIRAI

    PregPreg + Graves+ Graves’’ = PTU = PTU ((““PP’’ss””))

    RAI: Elderly with GravesRAI: Elderly with Graves’’, solitary toxic , solitary toxic nodulenodule

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Thyroid StormThyroid Storm

    Rare complication of Rare complication of thyrotoxicosisthyrotoxicosisPrecipitating factor:Precipitating factor:Stressful illnessStressful illness thyroid surgerythyroid surgeryDKADKA infectioninfectionsevere traumasevere trauma childbirthchildbirth

    High mortality rate:High mortality rate:20% pts. (coma or die)20% pts. (coma or die)

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Clinical Manifestations & Clinical Manifestations & TxTx

    Marked deliriumMarked deliriumSevere tachycardiaSevere tachycardiaVomitingVomitingDiarrheaDiarrheaDehydrationDehydrationHigh feverHigh fever

    Supportive therapy: Supportive therapy: IVF, cooling blankets, IVF, cooling blankets, glucoseglucosePTU q 6 HPTU q 6 HMethimazoleMethimazole q 1Hq 1HBeta blockersBeta blockersIodine Iodine HydrocortisoneHydrocortisone

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    HypothyroidismHypothyroidism

    0.80.8--1.0 % population1.0 % population3 x more common women3 x more common womenOnset adulthood and insidiousOnset adulthood and insidiousPrimary (90Primary (90--95%)95%)Autoimmune associated with other nonAutoimmune associated with other non--endocrine abnormalitiesendocrine abnormalities

    pernicious anemia, RA, SLE, pernicious anemia, RA, SLE, SjogrenSjogren’’ss, and Myasthenia Gravis., and Myasthenia Gravis.

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Primary HypothyroidismPrimary HypothyroidismAuto immuneAuto immune

    HashimotoHashimoto’’s s thyroiditisthyroiditis

    EndEnd--stage Gravesstage Graves’’ DiseaseDisease

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Primary HypothyroidismPrimary HypothyroidismIatrogenic Iatrogenic

    Radio Iodine therapyRadio Iodine therapyGland shrinksGland shrinks

    ThyroidectomyThyroidectomy

    MedicationsMedicationsLithiumLithiumAmiodoroneAmiodoroneInterferonInterferon

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Other CausesOther CausesInfiltrative Process Infiltrative Process AmyloidosisAmyloidosisLymphomaLymphomaSclerodermaScleroderma

    Congenital Hypothyroidism Congenital Hypothyroidism defects in enzymesdefects in enzymes

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Secondary HypothyroidismSecondary Hypothyroidism

    Failure of the pituitary gland or Failure of the pituitary gland or hypothalamushypothalamus

    NeoplasmNeoplasmSurgerySurgerySheehanSheehan’’s syndromes syndrome

    Cause deficiency in TSH or TRHCause deficiency in TSH or TRH low TSH, low FT4low TSH, low FT4

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    HashimotoHashimoto’’s s ThyroiditisThyroiditisChronic Lymphocyte Chronic Lymphocyte ThyroiditisThyroiditis

    Most prevalent form of thyroid autoimmune diseaseMost prevalent form of thyroid autoimmune diseaseGenetic propensity Genetic propensity HLAHLA--B8B8Hypothyroidism initial manifestationHypothyroidism initial manifestationHyperthyroidism < 5% patients Hyperthyroidism < 5% patients –– self limiting or self limiting or long standinglong standing

    HashitoxicosisHashitoxicosis, transient hyperthyroidism (severe), transient hyperthyroidism (severe)GravesGraves’’ TSI (thyroid stimulating TSI (thyroid stimulating immunoglobulinsimmunoglobulins))HashimotosHashimotos TSH receptor blocking antibodiesTSH receptor blocking antibodies

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    MyxedmaMyxedma ComaComaLifeLife--threatening hypothyroidismthreatening hypothyroidismObtundationObtundation, CO2 retention, coma, CO2 retention, comaAltered mental status is hallmarkAltered mental status is hallmarkCan be precipitated by sepsisCan be precipitated by sepsisHigh mortality, treat in ICUHigh mortality, treat in ICUThyroxineThyroxine bolus 300mcg, then 100mcg dailybolus 300mcg, then 100mcg dailyHydrocortisone 100mg IV bolusHydrocortisone 100mg IV bolus

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Hypo: SignsHypo: SignsDry skinDry skinCoarse hairCoarse hairThickened puffy featuresThickened puffy featuresNonNon--pitting edemapitting edemaCarpal tunnel syndromeCarpal tunnel syndromeSlow relaxation of DTRSlow relaxation of DTRLoss lateral portions of eyebrowsLoss lateral portions of eyebrowsBradycardiaBradycardiaGoiter (Goiter (hashimotohashimoto: rubbery, : rubbery, nonnon--tender,tender, possibly possibly nodular)nodular)

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Hypo: SymptomsHypo: SymptomsFatigue, lethargy, weaknessFatigue, lethargy, weaknessHeavy menstrual periods (Heavy menstrual periods (menorrhagiamenorrhagia))Slight weight gainSlight weight gainCold intoleranceCold intoleranceConstipationConstipationSlow Slow mentationmentation, inability to concentrate, inability to concentrateDepressionDepressionDiminished hearingDiminished hearing

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Hypothyroidism Lab ValuesHypothyroidism Lab ValuesPrimary: Primary: HighHigh TSH, TSH, LowLow FT4FT4Secondary: Secondary: LowLow TSH or normal, TSH or normal, LowLow FT4FT4Antibody titers: Antibody titers: presentpresentAnti-thyroglobulin antibodies (TGA)Anti-thyroid peroxidase antibodies (TPO)T3 not a good testT3 not a good testSubclinical Hypothyroidism: Subclinical Hypothyroidism: mild elevated or high normal TSH, serum FT4 normalmild elevated or high normal TSH, serum FT4 normal

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Hypothyroidism TreatmentHypothyroidism Treatment

    ••LevothyroxineLevothyroxine (T4) (T4) SynthroidSynthroid••Dose ranges 25mcg to 200 mcg dailyDose ranges 25mcg to 200 mcg daily••The T4 is converted into T3The T4 is converted into T3••Start lower in elderlyStart lower in elderly••Adjust dose every 4Adjust dose every 4--6 weeks6 weeks••Once stable, check levels twice yearlyOnce stable, check levels twice yearly

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Symptoms Key WordsSymptoms Key WordsHyperHyper

    Increase appetiteIncrease appetiteNervousNervousLoose stoolsLoose stoolsIrritabilityIrritabilityHeat intoleranceHeat intolerance

    HypoHypo

    Fatigue/LethargyFatigue/LethargyDepressedDepressedConstipationConstipationWeaknessWeaknessCold intoleranceCold intolerance

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    ThyroiditisThyroiditis

    Acute Acute suppurativesuppurative (rare)(rare)SubacuteSubacute painful (painful (DequervainDequervain’’ss))DrugDrug--induced (induced (AmiodaroneAmiodarone))Chronic lymphocytic (HashimotoChronic lymphocytic (Hashimoto’’s)s)Fibrous Fibrous thyroiditisthyroiditis (Riedel(Riedel’’s)s)

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Nontoxic GoiterNontoxic Goiter

    Thyroid levels are usually normalThyroid levels are usually normalSlowly enlarging thyroid gland over yearsSlowly enlarging thyroid gland over years5% of US population5% of US populationWomen > menWomen > menUsually asymptomatic unless impingingUsually asymptomatic unless impingingEndemic in iodine deficient areasEndemic in iodine deficient areas

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Solitary Thyroid NodulesSolitary Thyroid NodulesCommon in population, women>menCommon in population, women>menNodule must be over 1cm to be palpatedNodule must be over 1cm to be palpatedThyroid adenoma most common benign noduleThyroid adenoma most common benign noduleNodule of adenoma is encapsulatedNodule of adenoma is encapsulated

    Follicular adenoma is most commonFollicular adenoma is most commonHürthle (oxyphil)

    Papillary adenoma are very rarePapillary adenoma are very rare

    Bleeding into nodule causes pain, enlargementBleeding into nodule causes pain, enlargementMost nodules are benign (95%)Most nodules are benign (95%)

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Solitary Nodule Work UpSolitary Nodule Work UpHistory: Head or neck irradiationHistory: Head or neck irradiationPhysical exam: thyroid, lymph, systemicPhysical exam: thyroid, lymph, systemicTests: labs, US, RAIU, FNATests: labs, US, RAIU, FNACapsular invasion & vessel infiltration are Capsular invasion & vessel infiltration are hallmarks of malignancyhallmarks of malignancyNodules that concentrate iodine are Nodules that concentrate iodine are ““hothot””, , those that do not are those that do not are ““coldcold””Solitary nodules rarely cause extension or Solitary nodules rarely cause extension or pressure symptomspressure symptoms

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Thyroid CancerThyroid Cancer

    Rapid growingRapid growingPainlessPainlessSingle hard lesionSingle hard lesionMore common in women 3:1More common in women 3:1Worse in menWorse in men9% of thyroid cancers are fatal9% of thyroid cancers are fatal

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Thyroid Cancer TypesThyroid Cancer Types

    Papillary most common, least aggressivePapillary most common, least aggressiveFollicular type often metastasizesFollicular type often metastasizesAnaplasticAnaplastic type (bad!) mainly >60 type (bad!) mainly >60 yoyo, , least commonleast commonMedullaryMedullary typetype-- C cells, elevated C cells, elevated calcitonincalcitonin, found with MEN syndrome, found with MEN syndromeThyroid lymphoma seen in HashimotoThyroid lymphoma seen in Hashimoto’’ss

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Treatment of Thyroid CancerTreatment of Thyroid Cancer

    Total Total vsvs near total near total thyroidectomythyroidectomyLymph node dissection if neededLymph node dissection if neededRadiation therapyRadiation therapyRadioactive iodine therapyRadioactive iodine therapyChemotherapy as an adjunctChemotherapy as an adjunctT4 replacement will be neededT4 replacement will be needed

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Parathyroid glandParathyroid gland

    HypoparathyroidismHypoparathyroidism

    HyperparathyroidismHyperparathyroidism

    Public domain available at:http://upload.wikimedia.org/wikipedia/commons/7/75/Thyroidgland-intl.png

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Review PTHReview PTHIncrease Increase osteoclasticosteoclastic activity in bone activity in bone CaCa++ into circulationinto circulationIncrease renal tubular Increase renal tubular reabsorptionreabsorption of Caof Ca++

    Inhibits absorption of phosphate and Inhibits absorption of phosphate and bicarbbicarb by renal tubuleby renal tubuleSynthesis 1,25 Synthesis 1,25 dihydroxycholecalciferoldihydroxycholecalciferol by by kidney (active form of kidney (active form of Vit.DVit.D))

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    HypoparathyroidismHypoparathyroidismMost commonly seen following Most commonly seen following thyroidectomythyroidectomy, , surgical removal parathyroid adenomasurgical removal parathyroid adenomaDi GeorgeDi George’’s syndromes syndromeCongenital cardiac anomaliesCongenital cardiac anomaliesDamage heavy metals such as copper WilsonDamage heavy metals such as copper Wilson’’s disease s disease or iron (or iron (hemochromotosishemochromotosis, transfusion , transfusion hemosiderosishemosiderosis))GranulomasGranulomasRiedelRiedel’’s s thyroiditisthyroiditisMagnesium deficiency (Magnesium deficiency (malabsorptionmalabsorption chronic ETOH)chronic ETOH)PseudohypoparathyroidismPseudohypoparathyroidism

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Clinical Features S&SClinical Features S&S

    Cardiac arrhythmias, Cardiac arrhythmias, prolongprolong QT intervalQT intervalRickets, Rickets, osteomalaciaosteomalaciaNeuromuscular Neuromuscular irritabilityirritability

    CircumoralCircumoral/fingers, /fingers, toes numbness, toes numbness, tinglingtinglingTetanyTetany: hyperactive : hyperactive DTR, DTR, ChovestekChovestek’’ss Sign, Sign, TrousseauTrousseau’’ss signsign

    CataractsCataractsNails Nails –– thin, brittlethin, brittleSkin Skin –– dry, scalydry, scalyLoss hair Loss hair (eyebrows)(eyebrows)Defective teeth Defective teeth (childhood)(childhood)

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Think Think HypocalcemiaHypocalcemia!!

    ChovostekChovostek’’ss sign:sign:Tapping facial nerve elicits contraction of Tapping facial nerve elicits contraction of facial musclesfacial muscles

    TrousseauTrousseau’’s sign:s sign:inflating BP cuff to pressure higher systolic inflating BP cuff to pressure higher systolic BP x 3 minutes to elicit carpal spasmsBP x 3 minutes to elicit carpal spasms

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Labs and TreatmentLabs and Treatment

    LabsLabsLow CalciumLow CalciumLow PTHLow PTHHigh phosphate High phosphate Alkaline Alkaline phosphatasephosphatasenormalnormal

    TreatmentTreatmentIIV calcium V calcium gluconategluconateseveresevere

    Calcium & Calcium & VitVit DDmaintenancemaintenance

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    HyperparathyroidismHyperparathyroidism

    PRIMARYPRIMARY

    SECONDARYSECONDARY

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Primary HyperparathyroidismPrimary Hyperparathyroidism

    HighHigh PTH, PTH, HighHigh CaCa++Excessive secretion of PTH by one or more Excessive secretion of PTH by one or more glandsglandsWomen 3x more commonWomen 3x more commonPtPt’’s > 50 s > 50 yoyoSingle parathyroid adenoma (80%)Single parathyroid adenoma (80%)Hyperplasia (20%)Hyperplasia (20%)Carcinoma (

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Secondary Secondary HyperparathyroidismHyperparathyroidism

    HighHigh PTH, PTH, LowLow or or Normal Normal CaCa++Chronic Renal FailureChronic Renal FailureVitamin D deficiencyVitamin D deficiency

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Signs and SymptomsSigns and Symptoms

    BonesBonesStonesStonesGroansGroans

    Psychiatric overtonesPsychiatric overtonesOther signsOther signs

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    BonesBones

    Bone achesBone achesArthralgiaArthralgiaPathologic Pathologic fxfx’’ss ––OsteitisOsteitis fibrosafibrosa cysticacystica““brown tumorsbrown tumors”” or cysts of the jawor cysts of the jaw

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    StonesStones(urinary tract manifestations)(urinary tract manifestations)

    Renal stonesRenal stonesNephrocalcinosisNephrocalcinosisPolydipsiaPolydipsiaPolyuriaPolyuriaHypercalcemiaHypercalcemia induced induced nephrogenicnephrogenic DIDI

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    GroansGroans

    Muscle painMuscle painWeaknessWeaknessPancreatitisPancreatitisPUDPUDGoutGoutConstipationConstipation

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Psychiatric OvertonesPsychiatric Overtones

    DepressionDepressionFatigueFatigueAnorexiaAnorexiaSleep disturbanceSleep disturbanceAnxietyAnxietyLethargyLethargy

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Other signsOther signs

    Shortened QT interval (EKG)Shortened QT interval (EKG)

    Decreased DTRDecreased DTR

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Laboratory Laboratory

    Elevated PTH, CaElevated PTH, Ca++ (confirms diagnosis)(confirms diagnosis)CaCa+ + > 10.5 mg/> 10.5 mg/dLdL, phosphate < 2.5 mg/, phosphate < 2.5 mg/dLdLHypercalciuriaHypercalciuria, elevated Alkaline , elevated Alkaline PhosphatasePhosphatase (bone disease)(bone disease)The best The best immunoradiometricimmunoradiometric assayassay

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    TreatmentTreatmentSurgerySurgery

    MedicalMedicalIV hydrationIV hydrationBisphosphonatesBisphosphonatesFurosemideFurosemide

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    AVOID:AVOID:

    Large doses ofLarge doses of…………..VitVit A, A, VitVit D and Calcium D and Calcium (Antacids/ supplements/additives)(Antacids/ supplements/additives)

    ThiazideThiazide diureticsdiuretics

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Adrenal GlandsAdrenal Glands

    CushingCushing’’s syndromes syndrome

    CorticoadrenalCorticoadrenal insufficiencyinsufficiency

    NeoplasticNeoplastic Disease Disease

    Public domain available at:http://commons.wikimedia.org/wiki/File:Illu_adrenal_gland.jpg

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Adrenal HormonesAdrenal Hormones

    GlucocorticoidsGlucocorticoids = = CortisolCortisolMineralcorticoidsMineralcorticoids = Aldosterone= AldosteroneAndrogens: precursors of sex steroidsAndrogens: precursors of sex steroidsCatecholaminesCatecholamines: epinephrine and : epinephrine and norepinephrinenorepinephrine

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    GlucocorticoidsGlucocorticoids = = CortisolCortisolHelp body respond to stressHelp body respond to stressMaintain BPMaintain BPCV functionCV functionSlow immune system inflammatory Slow immune system inflammatory responseresponseMaintain levels of glucoseMaintain levels of glucoseRegulate protein/fat/carbohydrate Regulate protein/fat/carbohydrate metabolismmetabolism

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    MineralcorticoidsMineralcorticoids = Aldosterone= Aldosterone

    Maintains blood pressureMaintains blood pressureMaintains water and salt balance Maintains water and salt balance Help kidneys retain NaHelp kidneys retain Na++, excrete K, excrete K++

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    ACTHACTH

    Public domain available at:http://commons.wikimedia.org/wiki/File:ACTH_Negative_Feedback.svg

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    ACTHACTHAdrenocorticotropicAdrenocorticotropic hormonehormoneHypothalamus Hypothalamus CRHCRH pituitarypituitaryPituitary Pituitary ACTH ACTH ACTH stimulates adrenal cortex ACTH stimulates adrenal cortex cortisolcortisolExcess ACTH Excess ACTH adrenal hyperplasiaadrenal hyperplasiaDeficiency ACTH Deficiency ACTH adrenal atrophyadrenal atrophyCortisolCortisol inhibits CRH & ACTH secretioninhibits CRH & ACTH secretion

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    CushingCushing’’s Disease s Disease Excess Excess ACTHACTH

    CushingCushing’’s disease (ACTH excess) is caused s disease (ACTH excess) is caused by ACTH secreting pituitary by ACTH secreting pituitary microadenomamicroadenomaCushingCushing’’s syndrome (s syndrome (cortisolcortisol excess) is excess) is the effects of excess the effects of excess cortisolcortisol on the bodyon the bodyWomen affected 8 times more oftenWomen affected 8 times more oftenCushingCushing’’s disease accounts for 70% of s disease accounts for 70% of CushingCushing’’s syndromes syndrome

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    CausesCauses

    Iatrogenic CushingIatrogenic Cushing’’s Syndromes Syndrome (most common(most common cause)cause)

    ACTH secreting adenoma of pituitary = ACTH secreting adenoma of pituitary = CushingsCushingsDisease (43%) Disease (43%) (second most common cause)(second most common cause)

    Adrenal Adenoma and Carcinoma (10Adrenal Adenoma and Carcinoma (10--15%)15%)

    Ectopic ACTH (10Ectopic ACTH (10--15%)15%)

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    CushingCushing’’s Diseases DiseaseCentral obesityCentral obesityHirsutismHirsutismMoon faceMoon face““buffalo humpbuffalo hump””Purple Purple striaestriaeLanugoLanugo hairhairAcneAcne

    Easy bruisingEasy bruisingSupraclavicularSupraclavicular fat fat padspadsProtuberant abdomenProtuberant abdomenThin extremitiesThin extremitiesHTNHTNIncrease infectionsIncrease infections

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    How to Diagnose How to Diagnose CushingsCushingsDisease?Disease?

    Initial screening Initial screening Low dose Low dose DexamethasoneDexamethasone suppression testsuppression test24 hour free urinary 24 hour free urinary cortisolcortisol levellevel

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    What is my source of ACTH?What is my source of ACTH?

    High dose High dose DexamethasoneDexamethasone Suppression testSuppression test> 50% suppression > 50% suppression cortisolcortisol pituitarypituitary

    MRI of pituitaryMRI of pituitary

    < 50% suppression < 50% suppression cortisolcortisol ectopic ectopic ACTH tumorACTH tumor

    CT of appropriate regionCT of appropriate region

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Ectopic ACTH producersEctopic ACTH producers

    Small cell carcinoma (lung) Small cell carcinoma (lung) ““Oat cellOat cell””

    Thyroid, Thyroid, thymomasthymomas

    Pancreatic islet cellPancreatic islet cell

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Treatment of CushingTreatment of Cushing’’ss

    Iatrogenic CushingIatrogenic Cushing’’s: Taper steroidss: Taper steroids

    Pituitary CushingPituitary Cushing’’s: s: transsphenoidaltranssphenoidal removal removal of pituitary adenomaof pituitary adenoma

    Adrenal adenoma or carcinoma: Adrenal adenoma or carcinoma: adrenalectomyadrenalectomy

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    CorticoadrenalCorticoadrenal InsufficiencyInsufficiency

    ““AddisonAddison’’s diseases disease””

    Public domain available at:http://commons.wikimedia.org/wiki/File:Illu_adrenal_gland.jpg UMDNJ PANCE/PANRE Review Course

    (becoming Rutgers July 1, 2013)

    UMDNJ PANCE/PANRE Review UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, Course (becoming Rutgers July 1,

    2013)2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Causes of Causes of Destruction or Dysfunction Destruction or Dysfunction

    of Adrenal Corticesof Adrenal Cortices

    PrimaryPrimary (ACTH independent)(ACTH independent)AutoimmuneAutoimmuneAdrenalectomyAdrenalectomyInfection (TB/fungal)Infection (TB/fungal)BleedBleedMetastaticMetastaticCongenitalCongenital

    Secondary Secondary (ACTH dependent) (ACTH dependent) SteroidsSteroidsHypopituitarismHypopituitarismTraumaTraumaACTH deficiencyACTH deficiency

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    CortiocadrenalCortiocadrenal Insufficiency Insufficiency ““AddisonAddison’’s diseases disease””

    Autoimmune destruction Autoimmune destruction most common cause Addisonmost common cause Addison’’ss80% spontaneous cases80% spontaneous cases

    Infectious diseases Infectious diseases –– tuberculosis tuberculosis most common cause worldwidemost common cause worldwide

    Iatrogenic Iatrogenic B/L B/L adrenalectomyadrenalectomy

    MetastaticMetastaticSecondary adrenal insufficiency Secondary adrenal insufficiency

    abrupt cessation of exogenous steroidsabrupt cessation of exogenous steroids

    pituitarypituitary failurefailureUMDNJ PANCE/PANRE Review Course

    (becoming Rutgers July 1, 2013)

    Clinical FeaturesClinical FeaturesGI symptomsGI symptoms: anorexia, N/V, vague : anorexia, N/V, vague abdominal pain, wt. lossabdominal pain, wt. lossMentalMental: lethargy, confusion, psychosis: lethargy, confusion, psychosisHypoglycemiaHypoglycemiaHypotensionHypotension (orthostatic)(orthostatic)HyperpigmentationHyperpigmentation –– knuckles, elbows, knuckles, elbows, knees, post. neck, knees, post. neck, palmarpalmar creases, nail creases, nail beds (primary insufficiency)beds (primary insufficiency)OtherOther: irregular or absent menses: irregular or absent menses

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Diagnostic LabsDiagnostic Labs

    Serum NaSerum Na++ low low (90%)(90%)Serum KSerum K+ + high high (65% primary disease)(65% primary disease)Fasting glucose lowFasting glucose lowLow Low levels of AM levels of AM cortisolcortisol ( 200 mg/dLdL) = ) = diagnosticdiagnosticLow ACTH = secondaryLow ACTH = secondaryEosinophiliaEosinophilia, , neutropenianeutropenia, , lymphocytosislymphocytosis

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    CosyntropinCosyntropin test (stimulation)test (stimulation)

    Give ACTH (Give ACTH (cosyntropincosyntropin-- parenterallyparenterally))Measure serum Measure serum cortisolcortisol 3030--60 min60 minNormal rise to at least 20 mcg/Normal rise to at least 20 mcg/dLdLLess than rise of 20 mcg/Less than rise of 20 mcg/dLdL –– suspicious suspicious for adrenal insufficiencyfor adrenal insufficiency

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    TreatmentTreatment

    HydrocortisoneHydrocortisone -- glucocorticoidglucocorticoidPrednisone Prednisone 2020--40mg 40mg popo QD QD HydrocortisoneHydrocortisone 5050--100mg q6hr IV 100mg q6hr IV ((““stressstress””situationssituations))

    FludrocortisoneFludrocortisone –– mineralocorticoidmineralocorticoidFlorinefFlorinef 0.10.1--0.2mg 0.2mg popo QDQDEnsure adequate salt intakeEnsure adequate salt intake

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    PheochromocytomaPheochromocytoma

    Rare cause of HTN, age 40Rare cause of HTN, age 40--60 onset60 onsetMost are due to unilateral Most are due to unilateral medullarymedullary tumortumorBilateral type tends to run in familiesBilateral type tends to run in familiesRule of 10Rule of 10’’s: 10% bilateral, 10% extras: 10% bilateral, 10% extra--adrenal, adrenal, 10% malignant, 10% familial, 10% pediatric, 10% malignant, 10% familial, 10% pediatric, 10% show no HTN10% show no HTNPalpitations, diaphoresis, and headachePalpitations, diaphoresis, and headachePicture of refractory or labile HTNPicture of refractory or labile HTN

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Presentation and Laboratory Presentation and Laboratory ValuesValues

    Family Family HxHx of of pheochromocytomapheochromocytoma or MENor MENFirst do 24hr urine First do 24hr urine catecholaminescatecholamines (avoid (avoid caffeine, vanilla, fruits)caffeine, vanilla, fruits)False (+): shock, hypoglycemia, stress, False (+): shock, hypoglycemia, stress, clonidineclonidinewithdrawal, withdrawal, TCAsTCAs, and , and MAOIsMAOIsClonidineClonidine suppression suppression test if above equivocaltest if above equivocal

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    TreatmentTreatment

    Adrenergic blockade for 3Adrenergic blockade for 3--4 weeks4 weeks––PhenoxybenzaminePhenoxybenzamine POPO––PhentolaminePhentolamine IVIV

    Surgical laparoscopic Surgical laparoscopic adrenalectomyadrenalectomyFollow up catecholamine testing neededFollow up catecholamine testing neededAdjunctive radiation and chemotherapy Adjunctive radiation and chemotherapy

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    An 8 yr. old boy presents with his mother who states that he An 8 yr. old boy presents with his mother who states that he has become overweight during the past year and has little has become overweight during the past year and has little energy, sleeps more, and is cold all the time. His growth energy, sleeps more, and is cold all the time. His growth curve has fallen from the 50curve has fallen from the 50th%th% to the 5to the 5th%th% for height, but his for height, but his weight has increased from the 50weight has increased from the 50th%th% to 90to 90th%th%. On PE he is . On PE he is obese, has thin hair, immature obese, has thin hair, immature faciesfacies, and slowed reflexes. , and slowed reflexes. What is the cause of his symptoms?What is the cause of his symptoms?

    1.1. AcromegalyAcromegaly2.2. CushingCushing’’s syndromes syndrome3.3. DwarfismDwarfism4.4. HypothyroidismHypothyroidism

    UMDNJ PANCE/PANRE Review Course UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)(becoming Rutgers July 1, 2013)

    An 8 yr. old boy presents with his mother who states that he An 8 yr. old boy presents with his mother who states that he has become overweight during the past year and has little has become overweight during the past year and has little energy, sleeps more, and is cold all the time. His growth energy, sleeps more, and is cold all the time. His growth curve has fallen from the 50curve has fallen from the 50th%th% to the 5to the 5th%th% for height, but his for height, but his weight has increased from the 50weight has increased from the 50th%th% to 90to 90th%th%. On PE he is . On PE he is obese, has thin hair, immature obese, has thin hair, immature faciesfacies, and slowed reflexes. , and slowed reflexes. What is the cause of his symptoms?What is the cause of his symptoms?

    1.1. AcromegalyAcromegaly2.2. CushingCushing’’s syndromes syndrome3.3. DwarfismDwarfism4.4. HypothyroidismHypothyroidism

    UMDNJ PANCE/PANRE Review Course UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)(becoming Rutgers July 1, 2013)

    A 28 yr. old presents to the ED with confusion and agitation. A 28 yr. old presents to the ED with confusion and agitation. He appears intoxicated and is unable to provide a history. On He appears intoxicated and is unable to provide a history. On exam he has mild exam he has mild proptosisproptosis, is , is tachycardictachycardic with regular with regular rhythm, neck fullness, a fine tremor, and brisk reflexes. While rhythm, neck fullness, a fine tremor, and brisk reflexes. While in the ED he vomits x 3. All labs are normal.in the ED he vomits x 3. All labs are normal.What is the most likely diagnosis? What is the most likely diagnosis?

    1.1. AddisonAddison’’s diseases disease2.2. Diabetic Diabetic ketoacidosisketoacidosis3.3. Thyroid stormThyroid storm4.4. Toxic adenomaToxic adenoma

    UMDNJ PANCE/PANRE Review Course UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)(becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    A 28 yr. old presents to the ED with confusion and agitation. A 28 yr. old presents to the ED with confusion and agitation. He appears intoxicated and is unable to provide a history. On He appears intoxicated and is unable to provide a history. On exam he has mild exam he has mild proptosisproptosis, is , is tachycardictachycardic with regular with regular rhythm, neck fullness, a fine tremor, and brisk reflexes. While rhythm, neck fullness, a fine tremor, and brisk reflexes. While in the ED he vomits x 3. All labs are normal.in the ED he vomits x 3. All labs are normal.What is the most likely diagnosis? What is the most likely diagnosis?

    1.1. AddisonAddison’’s diseases disease2.2. Diabetic Diabetic ketoacidosisketoacidosis3.3. Thyroid stormThyroid storm4.4. Toxic adenomaToxic adenoma

    UMDNJ PANCE/PANRE Review Course UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)(becoming Rutgers July 1, 2013)

    Where is thyroidWhere is thyroid--stimulating hormone stimulating hormone (TSH) produced?(TSH) produced?

    1.1. Anterior pituitaryAnterior pituitary2.2. Posterior pituitary Posterior pituitary 3.3. ZonaZona fasciculatafasciculata4.4. ZonaZona glomerulosaglomerulosa

    UMDNJ PANCE/PANRE Review Course UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)(becoming Rutgers July 1, 2013)

    Where is thyroidWhere is thyroid--stimulating hormone stimulating hormone (TSH) produced?(TSH) produced?

    1.1. Anterior pituitaryAnterior pituitary2.2. Posterior pituitary Posterior pituitary 3.3. ZonaZona fasciculatafasciculata4.4. ZonaZona glomerulosaglomerulosa

    UMDNJ PANCE/PANRE Review Course UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)(becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Over the past year a 21 yr. old female has developed Over the past year a 21 yr. old female has developed amenorrhea and milky nipple discharge. She is not taking any amenorrhea and milky nipple discharge. She is not taking any medications and is sexually active but doesnmedications and is sexually active but doesn’’t wish to become t wish to become pregnant. Her serum HCG is negative; pregnant. Her serum HCG is negative; prolactinprolactin 300 mg/300 mg/dLdL; ; MRI reveals a 3 mm mass in the pituitary. What is the most MRI reveals a 3 mm mass in the pituitary. What is the most appropriate therapy at this time?appropriate therapy at this time?

    1.1. BromocriptineBromocriptine ((ParlodelParlodel))2.2. Monthly IM Monthly IM

    medroxyprogesteronemedroxyprogesterone3.3. Sequential Sequential OCOC’’ss4.4. TransphenoidalTransphenoidal tumor tumor

    resectionresection

    UMDNJ PANCE/PANRE Review Course UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)(becoming Rutgers July 1, 2013)

    Over the past year a 21 yr. old female has developed Over the past year a 21 yr. old female has developed amenorrhea and milky nipple discharge. She is not taking any amenorrhea and milky nipple discharge. She is not taking any medications and is sexually active but doesnmedications and is sexually active but doesn’’t wish to become t wish to become pregnant. Her serum HCG is negative; pregnant. Her serum HCG is negative; prolactinprolactin 300 mg/300 mg/dLdL; ; MRI reveals a 3 mm mass in the pituitary. What is the most MRI reveals a 3 mm mass in the pituitary. What is the most appropriate therapy at this time?appropriate therapy at this time?

    1.1. BromocriptineBromocriptine ((ParlodelParlodel))2.2. Monthly IM Monthly IM

    medroxyprogesteronemedroxyprogesterone3.3. Sequential Sequential OCOC’’ss4.4. TransphenoidalTransphenoidal tumor tumor

    resectionresection

    UMDNJ PANCE/PANRE Review Course UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)(becoming Rutgers July 1, 2013)

    A 25 yr old presents with extreme weakness and A 25 yr old presents with extreme weakness and dizziness. On PE he appears depressed; BP 90/70. He dizziness. On PE he appears depressed; BP 90/70. He has dark skin and has dark skin and hyperpigmentedhyperpigmented creases on his creases on his palms. Labs: low sodium; high potassium, calcium and palms. Labs: low sodium; high potassium, calcium and urea. What is the most likely diagnosis?urea. What is the most likely diagnosis?

    1.1. AddisonAddison’’s diseases disease2.2. CushingCushing’’s syndromes syndrome3.3. PheochromocytomaPheochromocytoma4.4. Primary Primary

    hyperaldosteronismhyperaldosteronism

    UMDNJ PANCE/PANRE Review Course UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)(becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    A 25 yr old presents with extreme weakness and A 25 yr old presents with extreme weakness and dizziness. On PE he appears depressed; BP 90/70. He dizziness. On PE he appears depressed; BP 90/70. He has dark skin and has dark skin and hyperpigmentedhyperpigmented creases on his creases on his palms. Labs: low sodium; high potassium, calcium and palms. Labs: low sodium; high potassium, calcium and urea. What is the most likely diagnosis?urea. What is the most likely diagnosis?

    1.1. AddisonAddison’’s diseases disease2.2. CushingCushing’’s syndromes syndrome3.3. PheochromocytomaPheochromocytoma4.4. Primary Primary

    hyperaldosteronismhyperaldosteronism

    UMDNJ PANCE/PANRE Review Course UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)(becoming Rutgers July 1, 2013)

    A 46 yr old male complains that he has developed A 46 yr old male complains that he has developed coarse facial features and a large prominent jaw. He coarse facial features and a large prominent jaw. He states that his shoe size has increased over the last states that his shoe size has increased over the last year despite no weight gain. What additional finding year despite no weight gain. What additional finding will most likely be found on PE?will most likely be found on PE?

    1.1. Atrophy of the digitsAtrophy of the digits2.2. Deepening voiceDeepening voice3.3. Dry skinDry skin4.4. Enlarged testesEnlarged testes

    UMDNJ PANCE/PANRE Review Course UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)(becoming Rutgers July 1, 2013)

    A 46 yr old male complains that he has developed A 46 yr old male complains that he has developed coarse facial features and a large prominent jaw. He coarse facial features and a large prominent jaw. He states that his shoe size has increased over the last states that his shoe size has increased over the last year despite no weight gain. What additional finding year despite no weight gain. What additional finding will most likely be found on PE?will most likely be found on PE?

    1.1. Atrophy of the digitsAtrophy of the digits2.2. Deepening voiceDeepening voice3.3. Dry skinDry skin4.4. Enlarged testesEnlarged testes

    UMDNJ PANCE/PANRE Review Course UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)(becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    A 19 yr. old male presents to the ED with acute A 19 yr. old male presents to the ED with acute fatigue, vomiting, diarrhea, and anorexia. On PE he fatigue, vomiting, diarrhea, and anorexia. On PE he has postural dizziness and pigmented has postural dizziness and pigmented buccalbuccal mucosa. mucosa. Labs indicate Labs indicate hyponatremiahyponatremia, , hyperkalemiahyperkalemia and and glucose of 50 mg/glucose of 50 mg/dLdL. . What is the most likely diagnosis?What is the most likely diagnosis?

    1.1. Adrenal insufficiencyAdrenal insufficiency2.2. DM, type 1DM, type 13.3. MyxedemaMyxedema4.4. PheochromocytomaPheochromocytoma

    UMDNJ PANCE/PANRE Review Course UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)(becoming Rutgers July 1, 2013)

    A 19 yr. old male presents to the ED with acute A 19 yr. old male presents to the ED with acute fatigue, vomiting, diarrhea, and anorexia. On PE he fatigue, vomiting, diarrhea, and anorexia. On PE he has postural dizziness and pigmented has postural dizziness and pigmented buccalbuccal mucosa. mucosa. Labs indicate Labs indicate hyponatremiahyponatremia, , hyperkalemiahyperkalemia and and glucose of 50 mg/glucose of 50 mg/dLdL. . What is the most likely diagnosis?What is the most likely diagnosis?

    1.1. Adrenal insufficiencyAdrenal insufficiency2.2. DM, type 1DM, type 13.3. MyxedemaMyxedema4.4. PheochromocytomaPheochromocytoma

    UMDNJ PANCE/PANRE Review Course UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)(becoming Rutgers July 1, 2013)

    Diabetes MellitusDiabetes Mellitus

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    What is Diabetes Mellitus?What is Diabetes Mellitus?

    A disorder of carbohydrate metabolismA disorder of carbohydrate metabolismLack of insulinLack of insulinInsulin resistanceInsulin resistanceBoth insulin deficiency and resistanceBoth insulin deficiency and resistance

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    ClassificationClassification

    Type 1 Type 1 -- little or no endogenous insulin little or no endogenous insulin productionproductionType 2 Type 2 –– insulin resistance and/ or insulin resistance and/ or deficiencydeficiencyGestationalGestationalLADA (type 1.5)LADA (type 1.5)-- latent autoimmune diabetes in adults (+) GADMODYMODY-- maturity onset diabetes of the maturity onset diabetes of the youngyoung UMDNJ PANCE/PANRE Review Course

    (becoming Rutgers July 1, 2013)

    EpidemiologyEpidemiologyNearly 26 million people in the US have Nearly 26 million people in the US have diabetes, 7 million of whom may be diabetes, 7 million of whom may be undiagnosed and unaware of their undiagnosed and unaware of their conditionconditionResearch examining A1C levels found that 35% of U.S. adults aged 20 years or older had pre-diabetes (50% of those aged 65 years or older are considered pre-diabetic); an estimated 79 million Americans aged 20 years or older have pre-diabetes UMDNJ PANCE/PANRE Review Course

    (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Pathogenesis of DM type 1Pathogenesis of DM type 1

    Hereditary predisposition (Hereditary predisposition (HLAHLA--DR gene)DR gene)Autoimmune Autoimmune (90% islet cell AB)(90% islet cell AB)

    Islet CellIslet Cell CytoplasmicCytoplasmic AutoantibodiesAutoantibodies (ICA) (ICA) GlutamicGlutamic Acid Acid DecarboxylaseDecarboxylase AutoantibodiesAutoantibodies (GADA) (GADA) InsulinomaInsulinoma--AssociatedAssociated--2 2 AutoantibodiesAutoantibodies (IA(IA--2A) 2A) Insulin Insulin AutoantiboidiesAutoantiboidies (IAA) (IAA)

    Autoimmune destruction of beta cellsAutoimmune destruction of beta cellsInfiltration of pancreas with TInfiltration of pancreas with T--lymphocyteslymphocytes

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Pathogenesis of DM type 2Pathogenesis of DM type 2

    Genetically linkedGenetically linkedInadequate insulin secretionInadequate insulin secretionPeripheral insulin resistancePeripheral insulin resistanceAccelerated hepatic glucose productionAccelerated hepatic glucose production

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Type I vs. Type IIType I vs. Type II

    Onset: SuddenOnset: SuddenAge: Typically youngAge: Typically youngBody: Usually thinBody: Usually thinKetosis: CommonKetosis: CommonAutoantibodiesAutoantibodies: : PresentPresentEndogenous insulin: Endogenous insulin: low or absentlow or absent

    Onset: GradualOnset: GradualAge: Mostly adultsAge: Mostly adultsBody: usually obeseBody: usually obeseKetosis: RareKetosis: RareAutoantibodiesAutoantibodies: : AbsentAbsentEndogenous insulin: Endogenous insulin: normal, increased, normal, increased, decreaseddecreased

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Risk FactorsRisk FactorsAge (> 45 years old)Age (> 45 years old)Obesity Obesity Sedentary LifestyleSedentary LifestyleEthnicity (AfricanEthnicity (African--American, Hispanic, Asian)American, Hispanic, Asian)Family history Family history HTN, hypercholesterolemia, high triglyceridesHTN, hypercholesterolemia, high triglyceridesGestational diabetes, having a child >9lbsGestational diabetes, having a child >9lbsPCOSPCOS

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Diagnostic CriteriaDiagnostic Criteria

    Adapted from the ADA Standards of medical care in diabetesAdapted from the ADA Standards of medical care in diabetes--2011. 2011. Diabetes CareDiabetes Care. . 2011;34 (2011;34 (supplsuppl 1):S111):S11--S61.S61.

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    FBS GTT A1C

    Normal Blood Sugar 6.5%

    Screening Guidelines Screening Guidelines Asymptomatic individuals with risk factors Asymptomatic individuals with risk factors should be screened for diabetes if they are should be screened for diabetes if they are overweight (BMI > 25 kg/m2) and have overweight (BMI > 25 kg/m2) and have additional risk factorsadditional risk factorsBeginning at age 45 for those without Beginning at age 45 for those without other risk factors other risk factors Those with normal results and low risk Those with normal results and low risk should be reshould be re--tested at threetested at three--year intervalsyear intervals

    American Diabetes Association. Standards of Medical Care in DiabAmerican Diabetes Association. Standards of Medical Care in Diabetes etes -- 2010. 2010. Diabetes Care 2010:33;S11Diabetes Care 2010:33;S11--6161

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Testing Recommendations: ChildTesting Recommendations: Child

    OverweightOverweight, , Age 10 yrsAge 10 yrs or or onset of pubertyonset of pubertyBMI > 85BMI > 85thth percentile for age and sexpercentile for age and sexWeight for height > 85Weight for height > 85thth percentilepercentileWeight > 120% ideal for heightWeight > 120% ideal for height

    Plus Plus 2 risk factors2 risk factorsFamily historyFamily historyRaceRaceAcanthosisAcanthosis nigricansnigricans, HTN, dyslipidemia, PCOS, SGA, HTN, dyslipidemia, PCOS, SGAMaternal history of DM or GDMMaternal history of DM or GDM

    Frequency every Frequency every 3 years3 years

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Signs & SymptomsSigns & SymptomsPolyuriaPolyuria, , polydipsiapolydipsia, , polyphagiapolyphagiaInfectionsInfectionsWeaknessWeaknessLethargyLethargyNumbness and tinglingNumbness and tinglingBlurry visionBlurry visionWeight lossWeight loss

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Diabetes ComplicationsDiabetes Complications

    MicrovascularMicrovascular ComplicationsComplications::RetinopathyRetinopathyNeuropathyNeuropathyNephropathyNephropathy

    MacrovascularMacrovascular Complications:Complications:CVDCVD-- atherosclerosis atherosclerosis –– 110 0 cause of deathcause of death

    Poor immune functionPoor immune functionComplicated infectionsComplicated infections

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Morbidity and MortalityMorbidity and MortalityLeading cause of kidney failure, Leading cause of kidney failure,

    nontraumaticnontraumatic lowerlower--limb amputations, and limb amputations, and new cases of blindness among adults in new cases of blindness among adults in the USthe USMajor cause of heart disease and strokeMajor cause of heart disease and stroke

    1 in 3 suffer from severe periodontal 1 in 3 suffer from severe periodontal diseasediseaseSeventh leading cause of death in the USSeventh leading cause of death in the US

    *CDC National diabetes fact sheet: national estimates and gener*CDC National diabetes fact sheet: national estimates and general information on al information on diabetes and diabetes and prediabetesprediabetes in the United States, 2011. Atlanta, GA: U.S. Department of in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and PreveHealth and Human Services, Centers for Disease Control and Prevention, 2011.ntion, 2011.

    UMDNJ PANCE/PANRE Review Course UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)(becoming Rutgers July 1, 2013)

    Diabetic RetinopathyDiabetic RetinopathyCataractsCataractsGlaucomaGlaucomaProliferative retinopathyProliferative retinopathyneovascularizationneovascularization, scarring, scarring

    NonNon--Proliferative retinopathyProliferative retinopathyhemorrhages, exudates, hemorrhages, exudates, microaneursymsmicroaneursyms, venous , venous dilatationdilatation

    DM leading cause of BlindnessDM leading cause of BlindnessPublic domain available at:http://commons.wikimedia.org/wiki/Eye

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Diabetic NeuropathyDiabetic Neuropathy

    Peripheral neuropathy ( LE > UE )Peripheral neuropathy ( LE > UE )distally distally symmetric,symmetric,““stockingstocking glove patternglove pattern”” loss sensation loss sensation

    AutonomicAutonomicGastroparesisGastroparesis, urinary retention, postural hypotension, , urinary retention, postural hypotension,

    impotence, fecal incontinence impotence, fecal incontinence

    Silent MISilent MI

    Public domain available at:http://commons.wikimedia.org/wiki/File:Derived_Neuron_schema_with_no_labels.svg

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Diabetic NephropathyDiabetic NephropathyHigh glucose levels cause High glucose levels cause polyuriapolyuria--renal renal hyperfiltrationhyperfiltrationChronic Chronic hyperfiltrationhyperfiltration leads to kidney leads to kidney damagedamageProteinuriaProteinuria –– early indicator of renal early indicator of renal diseasediseaseRapid progression to dialysis once Rapid progression to dialysis once creatininecreatinine reaches 3reaches 3--4 mg/dl4 mg/dl

    ESRDESRD--DM most common reason for HDDM most common reason for HDPublic domain available at:http://commons.wikimedia.org/wiki/File:Diffuse_proliferative_lupus_nephritis.jpg

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Systemic Vascular ChangesSystemic Vascular Changes

    AtherosclerosisAtherosclerosisHypertensionHypertensionCADCADPVDPVDStrokeStroke

    Public domain available at:http://commons.wikimedia.org/wiki/File:Aorta.jpg

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Poor immune functionPoor immune function

    VaginitisVaginitisPeriodonitisPeriodonitisUTIUTISinusitisSinusitisOtitisOtitis externaexterna/ media/ mediaCellulitisCellulitis

    Public domain available at:http://commons.wikimedia.org/wiki/File:Cellulitis_Left_Leg.JPGUMDNJ PANCE/PANRE Review Course

    (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Complicated InfectionsComplicated InfectionsGram negative pneumoniasGram negative pneumoniasInfected ulcersInfected ulcersGram negative sepsisGram negative sepsis

    Public domain available at:http://commons.wikimedia.org/wiki/File:ULCERCELLULITIS1.JPG

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Diabetic Diabetic immunosuppressionimmunosuppression

    Fungal infectionsFungal infectionsThrushThrushAspergilliosisAspergilliosisCholecystitisCholecystitis/ / cholangitischolangitispyelonephritispyelonephritis

    Public domain available at:http://commons.wikimedia.org/wiki/File:Fungal_tounge.jpg

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Hypoglycemia Hypoglycemia Signs and SymptomsSigns and Symptoms

    FSFS-- < 70 mg/< 70 mg/dLdLTachycardia, sweating, tremors, nausea, Tachycardia, sweating, tremors, nausea, hunger, anxietyhunger, anxietyConfusion, coma, seizure, death Confusion, coma, seizure, death

    TxTx: : 15 grams of glucose15 grams of glucose4 oz OJ or soda, 34 oz OJ or soda, 3--4 glucose tabs, 54 glucose tabs, 5--6 hard candies, 6 hard candies,

    glucagon IMglucagon IM

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    DKADKA-- Diabetic Diabetic KetoacidosisKetoacidosisUsually occurs in type 1Usually occurs in type 1 (insulin insufficiency)(insulin insufficiency)Diagnostic criteriaDiagnostic criteria--

    PG >250PG >250Ph 310No acidosisNo acidosisNo No ketonesketonesBicarbBicarb >15>15

    TriggersTriggers: infection, AMI, pancreatitis, poor compliance: infection, AMI, pancreatitis, poor compliance

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Treatment Treatment Hyperosmolar Hyperglycemic State

    Saline replacement Saline replacement -- (6(6--10 L)10 L)Regular Insulin IV Regular Insulin IV (15 units/ IV, 15 units SQ)(15 units/ IV, 15 units SQ)Potassium Potassium (10 (10 meqmeq to initial fluids)to initial fluids)Magnesium Magnesium (2 gm to initial fluids)(2 gm to initial fluids)Once glucose

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Treatment & Management of DMTreatment & Management of DM

    Self monitoringSelf monitoringInsulin/ oral medicationsInsulin/ oral medicationsDiet and exerciseDiet and exercisePatient educationPatient education

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Self MonitoringSelf Monitoring

    Used to adjust Used to adjust medication medication Improves glycemic Improves glycemic controlcontrolPatientPatient’’s involvement s involvement in their carein their care

    Public domain available at:http://commons.wikimedia.org/wiki/File:Glucose_test.JPG

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Balanced Diet Balanced Diet Moderate caloric restrictionModerate caloric restrictionModerate weight loss 5Moderate weight loss 5--9 kg goals9 kg goalsSpacing meals (especially Spacing meals (especially carbscarbs))Approach depends on lifestyleApproach depends on lifestyleVery low calorie diet usually NOT effective Very low calorie diet usually NOT effective for long term goals!for long term goals!

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    ExerciseExerciseImproves glucose Improves glucose tolerancetolerancePromotes good circulationPromotes good circulationMaintains good muscle Maintains good muscle tonetoneHelps maintain normal Helps maintain normal body weightbody weightReduces insulin Reduces insulin requirementsrequirementsRecommendation Recommendation 150min/week150min/week

    Public domain available at:http://commons.wikimedia.org/wiki/File:Exercise_machines_(284617740).jpg

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

    Oral AntiOral Anti--diabetic Agents (OAD)diabetic Agents (OAD)

    SensitizersSensitizers-- Inhibit the release of glucose Inhibit the release of glucose from the liver; improve sensitivity to from the liver; improve sensitivity to insulininsulin

    BiguanidesBiguanides-- Metformin (Metformin (GlucophageGlucophage, , FortametFortamet, , GlumetzaGlumetza, etc), etc)

    * Lactic Acidosis, elderly* Lactic Acidosis, elderly

    Thiazolidinediones (TZD) PPARy (gamma)Thiazolidinediones (TZD) PPARy (gamma)Rosiglitazone (Avandia),Pioglitazone (Actos)Rosiglitazone (Avandia),Pioglitazone (Actos)

    *Bladder Cancer, CHF*Bladder Cancer, CHF

    UMDNJ PANCE/PANRE Review Course UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)(becoming Rutgers July 1, 2013)

    Oral AntiOral Anti--diabetic Agents (OAD)diabetic Agents (OAD)

    SecretagoguesSecretagogues-- Stimulate the release of Stimulate the release of insulin from the pancreasinsulin from the pancreas

    SulfonylureasSulfonylureas (SU)(SU)Glipizide (Glipizide (GlucotrolGlucotrol), ), GlimepirideGlimepiride ((AmarylAmaryl), ), GlyburideGlyburide ((DiaBetaDiaBeta, , GlynaseGlynase))

    MeglitinidesMeglitinidesRepaglinideRepaglinide ((PrandinPrandin), ), NateglinideNateglinide ((StarlixStarlix))

    UMDNJ PANCE/PANRE Review Course UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)(becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Oral AntiOral Anti--diabetic Agents (OAD)diabetic Agents (OAD)

    DipeptidylDipeptidyl peptidasepeptidase--4 inhibitors (DPP4 inhibitors (DPP--4)4)--inhibitors inhibit the degradation of incretins (GLP-

    1 and GIP)SaxagliptinSaxagliptin ((OnglyzaOnglyza), ), SitagliptinSitagliptin ((JanuviaJanuvia), ), LinagliptinLinagliptin ((TradjentaTradjenta))

    AlphaAlpha--glucosidaseglucosidase inhibitors (AGI)inhibitors (AGI)-- Slow Slow the breakdown of starches and some sugarsthe breakdown of starches and some sugars

    AcarboseAcarbose ((PrecosePrecose), ), MiglitolMiglitol ((GlysetGlyset))

    UMDNJ PANCE/PANRE Review Course UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)(becoming Rutgers July 1, 2013)

    NonNon--insulin Injectablesinsulin InjectablesAmylin mimetics- It slows the rate at which It slows the rate at which glucose is absorbed from the intestine, reduces the glucose is absorbed from the intestine, reduces the production of glucose by the liver by inhibiting the action production of glucose by the liver by inhibiting the action of glucagonof glucagon

    Pramlintide (Symlin)

    Incretin mimetics- GLP-1 agonist- Enhances Enhances insulin secretion by the pancreatic betainsulin secretion by the pancreatic beta--cell, suppresses cell, suppresses inappropriately elevated glucagon secretion, slows inappropriately elevated glucagon secretion, slows gastric emptying which produces satietygastric emptying which produces satiety

    Liraglutide (Victoza), Exenatide (Byetta), Exenatide extended-release (Bydureon)

    UMDNJ PANCE/PANRE Review Course UMDNJ PANCE/PANRE Review Course UMDNJ PANCE/PANRE Review Course

    (becoming Rutgers July 1, 2013)(becoming Rutgers July 1, 2013)

    Human Insulin Profiles Human Insulin Profiles (Rapid and Intermediate Acting, Premix)(Rapid and Intermediate Acting, Premix)

    INSULININSULIN ONSETONSET PEAKPEAK DURATIONDURATION

    NovolinNovolin®® (R), (R), HumalinHumalin®® (R)(R)

    Regular Regular

    3030--60 min60 min 22--4 hrs4 hrs 55--8 hr8 hr

    NovolinNovolin®® (N), (N), HumalinHumalin®® (N) (N)

    NPH NPH

    11--3 hrs3 hrs 44--10 hrs10 hrs 1818--24 hrs24 hrs

    HumulinHumulin®®

    70/30, 70/30, NovolinNovolin®®

    70/3070/30

    3030--60 min60 min VariesVaries Up to 24hrsUp to 24hrs

    HumalinHumalin®® 50/5050/50 3030--60 min60 min VariesVaries Up to 24hrsUp to 24hrs

    UMDNJ PANCE/PANRE Review Course (becoming Rutgers July 1, 2013)

  • UMDNJ PACE/PANRE Review Course becoming Rutgers July 1, 2013

    Insulin Analogs Insulin Analogs Basal (LongBasal (Long--acting) B